Today: 10 June 2026
Browse Category

Health News 8 August 2025 - 16 August 2025

Miracle Drugs, Mega Mergers & Outbreak Alerts – Biotech & Health News Roundup (Aug 15–16, 2025)

Miracle Drugs, Mega Mergers & Outbreak Alerts – Biotech & Health News Roundup (Aug 15–16, 2025)

Wegovy became the first GLP-1 therapy approved by the FDA for MASH, affecting about 5% of U.S. adults. Tonix’s Tonmya was cleared for fibromyalgia, the first new therapy in 15 years. Pfizer’s inclacumab failed a key sickle cell trial, and Oxbryta was withdrawn. BioNTech agreed to acquire CureVac in a $1.25 billion all-stock deal.
16 August 2025
··········
Blockbuster Breakthroughs, Setbacks & Surges: Biotech and Health News Roundup (Aug 11–12, 2025)

Blockbuster Breakthroughs, Setbacks & Surges: Biotech and Health News Roundup (Aug 11–12, 2025)

IO Biotech’s melanoma vaccine Cylembia plus Merck’s Keytruda missed statistical significance in Phase 3, with median progression-free survival of 19.4 months versus 11 months for Keytruda alone. The FDA approved PharmaTher’s ketamine (KETARx) for anesthesia and pain. A dengue outbreak in Pacific Island nations has infected over 16,500 and killed 17 in 2025, with Fiji, Samoa, and Tonga hardest hit.
12 August 2025
Breakthrough Cures, Big Pharma Shake-Ups & Health Policy Bombshells – Biotech/Health News (Aug 7–8, 2025)

Breakthrough Cures, Big Pharma Shake-Ups & Health Policy Bombshells – Biotech/Health News (Aug 7–8, 2025)

Scripps Research announced T7-ORACLE, a platform that accelerates protein evolution 100,000-fold in living cells, published Aug. 7 in Science. Harvard scientists reported in Nature that lithium reversed memory loss in Alzheimer’s mouse models. The FDA launched “PreCheck” to speed approval of U.S. drug plants. Regulators imposed new safety warnings on Bluebird Bio’s gene therapy Skysona.
8 August 2025
1 2 3 4

Stock Market Today

  • Stock Market Update June 9: Nasdaq Slumps Amid Tech Sell-Off and Risk-Off Sentiment
    June 9, 2026, 6:04 PM EDT. On June 9, the S&P 500 declined 0.26% to 7,386.65, and the Nasdaq Composite dropped 0.97% to 25,678.82, pressured by a renewed sell-off in technology and semiconductor stocks. Broadcom, Micron, AMD, and Intel led the losses, while Microsoft and Apple also fell despite new partnerships and AI capability concerns, respectively. The Dow Jones Industrial Average marginally rose 0.17% after a late recovery. Market volatility stemmed from profit-taking, risk reduction ahead of key U.S. inflation data, geopolitical tensions, and repositioning ahead of SpaceX's mega-IPO. Diversification is advised as investors shift away from tech to mitigate concentration risks. Meanwhile, The Motley Fool's Stock Advisor highlighted its top 10 growth stocks, excluding the S&P 500, emphasizing long-term investing opportunities.

Latest articles

Opendoor Faces Russell 3000 Deadline as Housing Market Remains Main Issue

Opendoor Faces Russell 3000 Deadline as Housing Market Remains Main Issue

9 June 2026
Opendoor shares rose 0.8% to $4.34 as investors positioned for its pending inclusion in the Russell 3000, set to take effect after June 26; index entry can boost demand from passive funds, but Opendoor’s Q1 revenue fell to $720 million with a wider $173 million net loss, and the company warned of risks from mortgage-rate volatility and housing market swings.
T1 Energy Stock Just Got Hit—KORE Deal Filing Puts Dilution Back in Focus

T1 Energy Stock Just Got Hit—KORE Deal Filing Puts Dilution Back in Focus

9 June 2026
T1 Energy shares plunged 7.4% to $8.46 after a new filing revealed details on stock-based payments for the KORE Power acquisition, raising dilution concerns as the deal’s share count will be set by a 10-day VWAP; a lower VWAP could mean more shares issued, pressuring existing holders amid sector-wide weakness and ongoing risks to closing and financing.
Navitas Tumbles as $500 Million Stock Sale Interrupts Nvidia Surge

Navitas Tumbles as $500 Million Stock Sale Interrupts Nvidia Surge

9 June 2026
Navitas Semiconductor shares plunged 6.6% to $22.85 after unveiling a $500 million stock-sale program, a board resignation, and weaker chip sector sentiment, as investors weighed dilution risks and uncertainty around AI-infrastructure demand despite a new product launch and recent ties to Nvidia’s MGX ecosystem.
Epsium Enterprise Shares Surge 72% in Volatile Nasdaq Trading

Epsium Enterprise Shares Surge 72% in Volatile Nasdaq Trading

9 June 2026
Epsium Enterprise soared 72.27% to close at $2.05 on record volume over 65 million shares—more than 200 times its average—before dropping 18.54% after hours to $1.67, as traders piled into the volatile Macau beverage wholesaler despite no major news and fundamentals showing falling revenue and a net loss.
Go toTop